跳至主要内容
临床试验/NCT02218788
NCT02218788已完成不适用

An Open-label, Retrospective, Postmarketing Study of Safety and Performance of Hydroxytite, a Calcium Hydroxyapatite Based Filler for Facial Soft Tissue Augmentation.

Panaxia Ltd0 个研究点目标入组 218 人开始时间: 2013年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Panaxia Ltd
入组人数
218
主要终点
To assess the safety of Hydroxytite (Crystalys) in subjects who received subdermal or deep-dermal injections

研究概览

简要总结

The purpose of this study is to assess the safety and performance of Hydroxytite in all subjects who have received sub dermal or deep dermal injections.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is over 18 years of age
  • Patient received Hydroxytite injection(s).

排除标准

  • Patient declines to participate in the study

结局指标

主要结局

To assess the safety of Hydroxytite (Crystalys) in subjects who received subdermal or deep-dermal injections

时间窗: 6 months

Adverse events or Serious adverse events, Injection site reactions.

次要结局

  • Performance(6 months)

研究者

发起方
Panaxia Ltd
申办方类型
Industry
责任方
Sponsor

相似试验